The 5 Best Peptide Clinics in Montana (2026) — Verified & Reviewed
Our 2026 list of the 5 best peptide clinics in Montana — verified picks for weight loss, recovery, anti-aging, and sexual wellness.
Read More
The 6 Best Peptide Clinics in Albuquerque (2026) — Verified & Reviewed
Our 2026 list of the 6 best peptide clinics in Albuquerque, NM — verified picks for weight loss, recovery, anti-aging, and sexual wellness.
Read More
The FTC Just Sued Hims & Hers Over Tracking Pixels. Your Clinic Probably Runs Them Too
The FTC, Utah and California sued Hims & Hers over health data sharing, billing and cancellations. The practices named are common at cash pay clinics.
Read More
The 6 Best Peptide Clinics in El Paso (2026) — Verified & Reviewed
Our 2026 list of the 6 best peptide clinics in El Paso, TX — verified picks for weight loss, recovery, anti-aging, and sexual wellness.
Read More
The 6 Best Peptide Clinics in Oklahoma City (2026) — Verified & Reviewed
Our 2026 list of the 6 best peptide clinics in Oklahoma City, OK — verified picks for weight loss, recovery, anti-aging, and sexual wellness.
Read More
The 6 Best Peptide Clinics in Omaha (2026) — Verified & Reviewed
Our 2026 list of the 6 best peptide clinics in Omaha, NE — verified picks for weight loss, recovery, anti-aging, and sexual wellness.
Read More
The Peptide Pricing Report: What 800+ Clinics Actually Charge in 2026
We analyzed advertised prices across 800+ peptide clinic websites. Here is the median, low and high for semaglutide, BPC-157, NAD+ and more.
Read More
FDA Panel Votes to Recommend BPC-157 for Pharmacy Compounding
An FDA advisory panel voted 8 to 6 to recommend adding BPC-157 to the 503A compounding list, breaking with agency staff. Here is what changes and what does not.
Read More
The 5 Best Peptide Clinics in Baltimore (2026) — Verified & Reviewed
Our 2026 list of the 5 best peptide clinics in Baltimore, MD — verified picks for weight loss, recovery, anti-aging, and sexual wellness.
Read More
Eli Lilly Will File Retatrutide, Its Most Powerful Weight-Loss Drug Yet, for FDA Approval in Early 2027
Eli Lilly just set a timeline for the most powerful weight-loss drug in development. Alongside its second-quarter earnings on July 23, 2026, the company said it will file retatrutide for FDA approval in early 2027, after two more Phase 3 trials succeeded. Retatrutide is the drug the obesity field has watched most closely, because in […]
Read More